Impact of Implantation Defects on Intermediate Outcome of Supera Stent for Popliteal Artery Stenosis

The implantation of the interwoven nitinol stents in patients with popliteal occlusive disease is safe and effective, with encouraging patency rates and clinical results after a 12-month follow-up. In our experience, we have not seen significant differences in patency at 1-year follow-up in patients with implantation defects.